Skip to content

Immuneering Corp

IMRX· NasdaqCore metricsCIK 1790340

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -3.43%
Market cap
$237.03M
64.76M shares
Filings
326
$0.00
FY 2023−100.0% FY23 yoy
-$24.19M
Q3 2026N/M FY25 yoy
-$25.79M
Q3 2026N/M FY25 yoy
-$51.84M
Q3 2026derivedN/M FY25 yoy
-$0.37
Q3 2026N/M FY25 yoy
$58.23M
Q3 2026+255.9% FY25 yoy
$237.03M
—
—
1.4×
-19.19%
—

FY2025 figures · derived

Price

$3.6645.70%$3.08past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2023
$2.31M0FY 2020FY 2021FY 2022FY 2023
PeriodEndedValueKindSource trail
FY 20232023-12-31$0reported
FY 20222022-12-31$316,952reported
FY 20212021-12-31$2,079,961reported
FY 20202020-12-31$2,311,535reported

Pharmaceutical preparations

Immuneering Corp is the 240th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Immuneering Corp · CIK 1790340 · Engraved from SEC EDGAR